NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Investors of record on Monday, August 6th will be given a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a yield of 3.80%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its Board of Directors has authorized a stock repurchase plan on Tuesday, May 22nd 2018, which authorizes the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 3.1% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its shares are undervalued.

Metlife Inc (NYSE:MET) issued its earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to analyst estimates of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The business's revenue for the quarter was up .6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.20 earnings per share. View Metlife's Earnings History.

17 brokerages have issued 12 month price targets for Metlife's stock. Their forecasts range from $47.00 to $78.00. On average, they expect Metlife's stock price to reach $57.0714 in the next year. This suggests a possible upside of 29.1% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decrease in short interest during the month of June. As of June 29th, there was short interest totalling 12,020,672 shares, a decrease of 28.9% from the June 15th total of 16,900,543 shares. Based on an average trading volume of 7,086,353 shares, the days-to-cover ratio is presently 1.7 days. Currently, 1.4% of the company's stock are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

Headlines about MET stock have trended positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Metlife earned a media sentiment score of 0.33 on Accern's scale. They also gave media stories about the financial services provider an impact score of 46.26 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Metlife's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BOARD OF DIRECTORS OF METLIFE INC (15.00%), NN Investment Partners Holdings N.V. (0.17%), Lodestar Investment Counsel LLC IL (0.04%), Gofen & Glossberg LLC IL (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.02%) and State of Alaska Department of Revenue (0.01%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Gofen & Glossberg LLC IL, Gateway Investment Advisers LLC, Cullinan Associates Inc., Fjarde AP Fonden Fourth Swedish National Pension Fund, CENTRAL TRUST Co, Cibc Bank USA, Ledyard National Bank and Raymond James Trust N.A.. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc., State of Alaska Department of Revenue, IFM Investors Pty Ltd, CHURCHILL MANAGEMENT Corp and DnB Asset Management AS. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.20.

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.